CBS 2019
CBSMD教育中心
English

Percutaneous LAA Occlusion

科研文章

荐读文献

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial Early Rhythm-Control Therapy in Patients with Atrial Fibrillation Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation: A Cohort Study Detection of Device-Related Thrombosis Following Left Atrial Appendage Occlusion A Comparison Between Cardiac Computed Tomography and Transesophageal Echocardiography​: A Comparison Between Cardiac Computed Tomography and Transesophageal Echocardiography

Consensus2017 Jan;19(1):4-15.

JOURNAL:Europace. Article Link

Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies

Tzikas A, Holmes DR Jr, Lewalter T et al. Keywords: atrial fibrillation; LAA closure; prevention; stroke

FULL TEXT PDF